42.14 -0.02 (-0.05%)
After hours: 4:02PM EDT
|Bid||42.16 x 1000|
|Ask||42.17 x 800|
|Day's Range||41.98 - 42.26|
|52 Week Range||32.98 - 46.67|
|Beta (3Y Monthly)||1.16|
|PE Ratio (TTM)||26.67|
|Forward Dividend & Yield||0.96 (2.42%)|
|1y Target Est||44.55|
There's hope for General Electric (NYSE:GE). Asset sales, a new CEO, and the promise of improved execution have brought investors back into GE stock. General Electric stock has risen 43% so far this year, handily outpacing the stock market.Source: Shutterstock I've been skeptical of the gains since GE stock hit $10, and I was bearish on GE stock long before that. For all the coverage GE receives, many aspects of its business aren't that attractive. GE Power serves declining end markets. Baker Hughes (NYSE:BHGE) is again challenging a 19-year low. Renewable energy hasn't proven to be a winner. GE Capital is still dealing with errors made years ago. * 5 Stocks to Buy for $20 or Less GE Healthcare and GE Aviation are certainly attractive. But with GE's heavily indebted balance sheet, and with its free cash flow expected to be negative this year, those two businesses simply are not attractive enough to make me upbeat on GE stock.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAll that said, I do understand why some are bullish on GE stock, and, truthfully, I would love to see the bullish thesis play out. GE is an iconic American company. Many investors lost a large amount of money on GE stock in recent years; they deserve a rebound.And there are reasons to be bullish on GE stock now. As I wrote just last month, GE management clearly is being more transparent. New CEO Larry Culp has sparked optimism. And to some extent, bad news is priced into GE stock. If Culp can turn around GE, General Electric stock is going to rise.I still believe that's too big an "if'," however. In that context, a few recent developments need to be monitored closely. GE Gets Transparent-ishCulp clearly has made a point of giving investors and analysts news when possible, whether it's good or bad. He told investors in March that GE would be cash flow-negative this year (excluding GE Capital) - and then reiterated that guidance last month. That's a noted departure from what InvestorPlace columnist Will Healy wisely called a "constant drip" of bad news, including lowered guidance, surprising charges by GE Capital, and execution missteps that weren't quickly revealed.But as Bloomberg noted last month, old habits are tough to break. CFO Jamie Miller admitted that the company had created "confusion" by touting the growth of GE Power's orders on its Q1 conference call in late April. That growth was questioned by JPMorgan Chase (NYSE:JPM) analyst Stephen Tusa, a prescient and longtime bear on General Electric stock.At a conference three weeks after the call, Miller said the company was referencing a report from a third-party. But as Bloomberg pointed out, the report included joint-venture orders and some orders that were already in the company's backlog before the quarter.For any other company, this would be a minor slip-up. For a company that's spent years seemingly twisting all news in its favor, it's a concerning step. GE Aviation StumblesAgain, the company's attractive businesses are Aviation and Healthcare. Those two segments can help keep GE afloat while it repairs its Power business and waits for a rebound in oil and gas and other smaller markets.But the GE9x engine is taking criticism by one of GE's key customers, Boeing (NYSE:BA). That manufacturer's 777x is facing potential delays after a second issue with GE's engine. Testing of the GE9x originally was delayed by three months due to a compressor issue. Further mechanical issues are delaying testing again, and GE is the "long pole in the tent," as Boeing CFO Greg Smith put it.This, too, isn't major news. Neither Boeing nor Airbus (OTCMKTS:EADSY) is going to abandon GE Aviation over these delays. But - as with the transparency issue - GE's history colors everything. A delay involving a key customer in a key business can't be seen as good news. GE's China ProblemThere's another major issue with buying GE stock: the economy needs to cooperate. A recession would interrupt the company's plans and offset Culp's optimism about 2020 and beyond.The trade war with China is a potential catalyst for a global slowdown. But even if that doesn't play out, China seems to be a significant risk for GE. For GE Healthcare, China was "a source of growth" last year, as the company put it in its 10-K. But that growth may have come from unsavory methods: the SEC is investigating GE, along with Philips (NYSE:PHG) and Siemens (OTCMKTS:SIEGY) for bribery.Moreover, Tusa and another analyst both have noted that China could create a new competitor for GE Power in the region. That market is too large, and GE Power too wobbly, to handle that type of blow.On top of all that, tariffs already are increasing GE's costs. And a prolonged trade war could undercut GE's brand. The problem with an industrial company like General Electric is that it can do everything right and still be upended by external factors. Culp's plans may not come to fruition if the news from China doesn't improve. On the Sidelines on General Electric StockTo those who are bullish on GE stock, these concerns probably seem like nit-picking. But that's what happens when a company loses trust.That aside, GE's turnaround path is not easy. It's facing real challenges now. GE stock didn't plunge just because of poor execution, bearish analysts, or uneven communication. Its fundamentals have been headed in the wrong direction for some time. It's going to take some time, and some help, for that to change.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 5 Red-Hot IPO Stocks to Buy for the Long Run * 5 Stocks to Buy for $20 or Less * 4 Dow Jones Stocks Ready to Rise Compare Brokers The post The Turnaround of General Electric Stock Takes a Few Hits appeared first on InvestorPlace.
June 17, 2019 Translational Research Institute for Space Health (TRISH) has selected two research studies leveraging Philips technology to evaluate if sleep can be.
Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its global research organization was awarded the Hendrik Lorentz Award for its pioneering role in the digital transformation of healthcare by applying data science and artificial intelligence (AI). The award, which is part of the Dutch Data Science Awards, was presented to Philips’ Chief Technology Officer and head of Research, Henk van Houten, at a ceremony in Den Bosch, the Netherlands.
Dutch health technology company Philips expects sales at its digital care business to grow this year as patients see the benefits of sharing more medical data with doctors, Chief Executive Frans van Houten told Reuters. Philips' connected care division offers platforms to remotely monitor patients and for doctors to share patient data. "We expect to see a positive trend in connected care this year, with sales growth picking up," Van Houten said in an interview.
STAMFORD, Conn., June 12, 2019 /PRNewswire/ -- Philips Norelco, a leader in male grooming technology, today announced a dynamic partnership with Barstool Sports, one of the country's fastest-growing sports and comedy media brands. Throughout the summer and fall, Philips Norelco will join Barstool Sports at some of America's biggest sporting events to give consumers the opportunity to try its portfolio of innovative shaving and grooming products for men first-hand. The partnership kicks off in June, with Philips Norelco's sponsorship of Barstool Breakfast Radio and Barstool's The Rundown, and culminates on Father's Day weekend at golf's third Major of the year and one of the most prestigious events on the tour calendar: the U.S. Open.
June 12, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that the exchange ratio for the dividend in shares for the year 2018 has.
June 11, 2019 Intelligent Connected Care solutions feature expansion of Philips IntelliSpace Enterprise Edition, Tasy EMR and Tele-ICU technology into.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2019 report: ‘Transforming healthcare experiences: Exploring the impact of digital health technology on healthcare professionals and patients’ . The report reflects independent research, commissioned by Philips, of what is required to accelerate the shift from volume-based to value-based care in the global drive for sustainable healthcare systems. The FHI finds that, despite the majority of individuals wanting access to their digital health record (DHR) and being prepared to share it more widely with healthcare professionals, insufficient data sharing currently takes place.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University of Vermont (UVM) Health Network, a leading provider of quality care, today announced a long-term, strategic partnership of 10 years. The partnership, which extends an existing relationship between the two organizations, will help support staff in providing high-quality care and advance efforts to improve the health of the population in Vermont and Northern New York.
Philips Hue might be one of the biggest names in smart home technology, butone product it has not yet managed to bring to market is a smart plug
May 30, 2019 Philips oncology solutions provide deeper insights for cancer teams to make better informed decisions and deliver more confident paths to treatment.
May 29, 2019 Stellarex is the only low-dose drug-coated balloon (DCB) to demonstrate a significant treatment effect and high safety profile through 3 years ILLUMENATE.
Moody's Investors Service ("Moody's") today downgraded the corporate family rating (CFR) of Bright Bidco B.V. (BBBV, Lumileds) to B3 from B1 and the probability of default rating to B3-PD from B1-PD. Moody's also downgraded the ratings of the senior secured term loan B (TLB) and the $200 million senior secured revolving credit facility, both with BBBV as the borrower, to B3 from B1. Moody's downgraded the ratings following weak financial 2018 figures, resulting from headwinds in BBBV's core markets automotive and consumer LED.
May 23, 2019 Large Midwest laboratory selects Philips IntelliSite Pathology Solution to further enhance efficiencies and quality of diagnostics for histology cases.
As Koninklijke Philips N.V. (AMS:PHIA) announced its earnings release on 31 March 2019, it seems that analyst...
May 20, 2019 Integrating best-in-class physiology, imaging and co-registration tools across the interventional lab workflow supports physicians in providing cardiac and.
The U.S. FBI is investigating corporate giants Johnson & Johnson, Siemens AG, General Electric Co and Philips for allegedly paying kickbacks as part of a scheme involving medical equipment sales in Brazil, two Brazilian investigators have told Reuters. Brazilian prosecutors suspect the companies channelled illegal payoffs to government officials to secure contracts with public health programs across the South American country over the past two decades. Brazilian authorities say more than 20 companies may have been part of a "cartel" that paid bribes and charged the government inflated prices for medical gear such as magnetic resonance imaging machines and prosthetics.
The U.S. FBI is investigating corporate giants Johnson & Johnson, Siemens AG, General Electric Co and Philips for allegedly paying kickbacks as part of a scheme involving medical equipment sales in Brazil, two Brazilian investigators have told Reuters. Brazilian prosecutors suspect the companies channeled illegal payoffs to government officials to secure contracts with public health programs across the South American country over the past two decades. Brazilian authorities say more than 20 companies may have been part of a "cartel" that paid bribes and charged the government inflated prices for medical gear such as magnetic resonance imaging machines and prosthetics.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Royal Philips N.V. Frankfurt am Main, May 17, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Royal Philips N.V. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Following the opening of the Windpark Krammer in the southwest of the Netherlands in the presence of His Majesty King Willem-Alexander, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, achieved another major milestone on the road to becoming carbon neutral by 2020. Under the terms of a power purchase agreement (PPA) between the windfarm’s operators and the Dutch Wind Consortium – a joint initiative by Philips, DSM, Google and Nouryon (formerly AkzoNobel Specialty Chemicals) – the consortium partners will jointly purchase 95% of the wind park’s total 102 MW output (generated by 34 wind turbines) for the next 15 years.